Circulating monocytes are not a major reservoir of HIV-1 in elite suppressors

Journal of Virology

Volumn 85, Issue 19, 2011, Pages 10399-10403

  Spivak, Adam M ^a   Salgado, Maria ^a   Alireza Rabi, S ^a   O'Connell, Karen A ^a   Blankson, Joel N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD14 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; GENOMIC DNA; VIRUS DNA;

CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL LINEAGE; EX VIVO STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION SENSITIVITY; MACROPHAGE; MONOCYTE; NONHUMAN; NOTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VIREMIA; VIRUS CARRIER; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION; VIRUS RESISTANCE;

DNA, VIRAL; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; MONOCYTES; PROVIRUSES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80053965899     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05409-11     Document Type: Note

References (62)

1. Alexaki, A., Y. Liu, and B. Wigdahl. 2008. Cellular reservoirs of HIV-1 and their role in viral persistence. Curr. HIV Res. 6:388-400.
2. Arfi, V., et al. 2008. Characterization of the early steps of infection of primary blood monocytes by human immunodeficiency virus type 1. J. Virol. 82:6557-6565.
3. Bagasra, O., and R. J. Pomerantz. 1993. Human immunodeficiency virus type I provirus is demonstrated in peripheral blood monocytes in vivo: a study utilizing an in situ PCR. AIDS Res. Hum. Retrovir. 9:69-76.
4. + elite suppressors. J. Virol. 83:88-97.
5. Bailey, J. R., et al. 2006. Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy. J. Virol. 80:4758-4770.
6. + T cells. J. Virol. 80:6441-6457.
7. + elite suppressors despite CTL escape mutations. J. Exp. Med. 203:1357-1369.
8. Blankson, J. N., et al. 2007. Isolation and characterization of replicationcompetent human immunodeficiency virus type 1 from a subset of elite suppressors. J. Virol. 81:2508-2518.
9. Calcaterra, S., G. Cappiello, A. Di Caro, A. R. Garbuglia, and A. Benedetto. 2001. Comparative analysis of total and integrated HIV-1 DNA in peripheral CD4 lymphocytes and monocytes after long treatment with HAART. J. Infect. 43:239-245.
10. Cavrois, M., C. De Noronha, and W. C. Greene. 2002. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 20:1151-1154.
11. Chun, T. W., et al. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183-188.
12. Chun, T. W., et al. 1997. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. U. S. A. 94:13193-13197.
13. Crowe, S., T. Zhu, and W. A. Muller. 2003. The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J. Leukoc. Biol. 74:635-641.
14. Delobel, P., et al. 2005. Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART. AIDS 19:1739-1750.
15. Duliost, A., et al. 2009. High frequency of neurocognitive disorders in older HIV-infected patients despite a sustained virological and immunological response on cART: the Sigma Study, abstr. 459, p. 220. 16th Conf. Retrovir. Opportunistic Infect., Montreal, Canada. CROI, Alexandria, VA.
16. + monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J. Immunol. 178:6581-6589.
17. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5:512-517.
18. Finzi, D., et al. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-1300.
19. + T cells during infection. J. Virol. 78:7883-7893.
20. Gartner, S., P. Markovits, D. M. Markovitz, R. F. Betts, and M. Popovic. 1986. Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA 256:2365-2371.
21. Gartner, S., et al. 1986. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233:215-219.
22. Giulian, D., K. Vaca, and C. A. Noonan. 1990. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250:1593-1596.
23. + patients on and off HAART. PLoS Pathog. 7:e1001300.
24. Hatano, H., et al. 2009. Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J. Virol. 83:329-335.
25. Ho, D. D., T. R. Rota, and M. S. Hirsch. 1986. Infection of monocyte/macrophages by human T lymphotropic virus type III. J. Clin. Invest. 77: 1712-1715.
26. Hufert, F. T., et al. 1991. Progression of HIV-1 infection. Monitoring of HIV-1 DNA in peripheral blood mononuclear cells by PCR. Arch. Virol. 120:233-240.
27. Hufert, F. T., D. von Laer, C. Schramm, A. Tarnok, and H. Schmitz. 1989. Detection of HIV-1 DNA in different subsets of human peripheral blood mononuclear cells using the PCR. Rapid communication. Arch. Virol. 106: 341-345.
28. Innocenti, P., M. Ottmann, P. Morand, P. Leclercq, and J. M. Seigneurin. 1992. HIV-1 in blood monocytes: frequency of detection of proviral DNA using PCR and comparison with the total CD4 count. AIDS Res. Hum. Retrovir. 8:261-268.
29. + T cells in HIV elite controllers. Clin. Infect. Dis. 51:233-238.
30. Lambotte, O., et al. 2005. HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. Clin. Infect. Dis. 41:1053-1056.
31. Lambotte, O., et al. 2000. Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 23:114-119.
32. Le Douce, V., G. Herbein, O. Rohr, and C. Schwartz. 2010. Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage. Retrovirology 7:32.
33. Lewin, S. R., et al. 1998. HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals. AIDS 12:719-727.
34. McElrath, M. J., R. M. Steinman, and Z. A. Cohn. 1991. Latent HIV-1 infection in enriched populations of blood monocytes and T cells from seropositive patients. J. Clin. Invest. 87:27-30.
35. Meuret, G., J. Bammert, and G. Hoffmann. 1974. Kinetics of human monocytopoiesis. Blood 44:801-816.
36. Mikovits, J. A., N. C. Lohrey, R. Schulof, J. Courtless, and F. W. Ruscetti. 1992. Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo. J. Clin. Invest. 90:1486-1491.
37. Naif, H. M., et al. 1998. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J. Virol. 72:830-836.
38. Neil, S., F. Martin, Y. Ikeda, and M. Collins. 2001. Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes. J. Virol. 75:5448-5456.
39. O'Brien, W. A., et al. 1994. Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J. Virol. 68:1258-1263.
40. O'Connell, K. A., J. R. Bailey, and J. N. Blankson. 2009. Elucidating the elite: mechanisms of control in HIV-1 infection. Trends Pharmacol. Sci. 30:631-637.
41. O'Connell, K. A., et al. 2010. Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus. J. Virol. 84:7018-7028.
42. Orenstein, J. M., C. Fox, and S. M. Wahl. 1997. Macrophages as a source of HIV during opportunistic infections. Science 276:1857-1861.
43. Potter, S. J., et al. 2004. HIV-1 compartmentalization in diverse leukocyte populations during antiretroviral therapy. J. Leukoc. Biol. 76:562-570.
44. + T cells from HIV-1-positive elite suppressors are fully susceptible to HIV-1 entry and productive infection. J. Virol. 85:979-986.
45. + T lymphocytes. J. Leukoc. Biol. 87:575-588.
46. + T cells from HIV controllers. Blood 118:955-964.
47. Schmitt, M. P., et al. 1990. Multiplication of human immunodeficiency virus in primary cultures of human Kupffer cells: possible role of liver macrophage infection in the physiopathology of AIDS. Res. Virol. 141:143-152.
48. Schnell, G., S. Spudich, P. Harrington, R. W. Price, and R. Swanstrom. 2009. Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia. PLoS Pathog. 5:e1000395.
49. Schnittman, S. M., et al. 1989. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245:305-308.
50. Schuitemaker, H. 1994. Macrophage-tropic HIV-1 variants: initiators of infection and AIDS pathogenesis? J. Leukoc. Biol. 56:218-224.
51. Shen, Y., et al. 1994. Blood monocytes from most human immunodeficiency virus type 1-infected patients do not carry proviral DNA. Clin. Diagn. Lab. Immunol. 1:531-537.
52. Sonza, S., et al. 1996. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J. Virol. 70:3863-3869.
53. Sonza, S., et al. 2001. Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. AIDS 15:17-22.
54. Spear, G. T., et al. 1990. Analysis of lymphocytes, monocytes, and neutrophils from human immunodeficiency virus (HIV)-infected persons for HIV DNA. J. Infect. Dis. 162:1239-1244.
55. Tacke, F., and G. J. Randolph. 2006. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211:609-618.
56. Tozzi, V., et al. 2007. Persistence of neuropsychologic deficits despite longterm highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J. Acquir. Immune Defic. Syndr. 45:174-182.
57. Triques, K., and M. Stevenson. 2004. Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes. J. Virol. 78: 5523-5527.
58. Weinberg, J. B., T. J. Matthews, B. R. Cullen, and M. H. Malim. 1991. Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J. Exp. Med. 174:1477-1482.
59. Whitelaw, D. M. 1972. Observations on human monocyte kinetics after pulse labeling. Cell Tissue Kinet. 5:311-317.
60. Whitelaw, D. M., M. F. Bell, and H. F. Batho. 1968. Monocyte kinetics: observations after pulse labeling. J. Cell Physiol. 72:65-71.
61. Wong, J. K., et al. 1997. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291-1295.
62. + monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J. Virol. 76:707-716.